Committee News
 
Next Meeting:  February 15, 2012
Packets mailed on or about February 8.
November 9:  Last committee meeting
Thank you for participating.
Theinopyridines reviewed in September.
SNRIs reviewed in September.
Uloric reviewed in May.
Hyperuricemia agents reviewed in May.
Proton pump inhibitors reviewed in May.
Protocol for emergent warfarin reversal reviewed in May.
Renvela reviewed in March.
Beta blockers reviewed in March.
Proton pump inhibitors reviewed in March.
Nplate reviewed in January.
Cleviprex reviewed in November 2009.
Inhaled anesthetics reviewed in November 2009.
Topical diclofenac reviewed in November 2009.
Low-molecular-weight heparins reviewed in November 2009.
 


New-Drug Reviews
 
Uloric (febuxostat) (May 2009)
Renvela (sevelamer) (March 2008)
Nplate (romiplostim) (January 2009)
Cleviprex (clevidiping injectable emulsion) (November 2008)
Entereg (alvimopan) (September 2008)
   



Drug-Class Reviews
 
Uloric (febuxostat) (May 2009)
Renvela (sevelamer) (March 2008)
Nplate (romiplostim) (January 2009)
Cleviprex (clevidiping injectable emulsion) (November 2008)
Entereg (alvimopan) (September 2008)